dc.contributor.author | Bekker, Roberto Bartholomeus Wilhelmus | |
dc.contributor.author | Fjellaksel, Richard | |
dc.contributor.author | Hjornevik, Trine | |
dc.contributor.author | Nuruddin, Syed | |
dc.contributor.author | Rafique, Waqas | |
dc.contributor.author | Hansen, Jørn H | |
dc.contributor.author | Sundset, Rune | |
dc.contributor.author | Haraldsen, Ira Hebold | |
dc.contributor.author | Riss, Patrick | |
dc.date.accessioned | 2021-01-08T09:12:10Z | |
dc.date.available | 2021-01-08T09:12:10Z | |
dc.date.issued | 2020-07-16 | |
dc.description.abstract | We report the synthesis, radiosynthesis and biological characterisation of two gonadotropin‐releasing hormone receptor (GnRH−R) antagonists with nanomolar binding affinity. A small library of GnRH−R antagonists was synthesised in 20–67 % overall yield with the aim of identifying a high‐affinity antagonist capable of crossing the blood–brain barrier. Binding affinity to rat GnRH−R was determined by autoradiography in competitive‐binding studies against [<sup>125</sup>l]buserelin, and inhibition constants were calculated by using the Cheng–Prusoff equation. The radioligands were obtained in 46–79 % radiochemical yield and >95 % purity and with a molar activity of 19–38 MBq/nmol by direct nucleophilic radiofluorination. Positron emission tomography imaging in rat under baseline conditions in comparison to pretreatment with a receptor‐saturating dose of GnRH antagonist revealed saturable uptake (0.1 %ID/mL) into the brain. | en_US |
dc.identifier.citation | Bekker, Fjellaksel, Hjornevik, Nuruddin, Rafique, Hansen, Sundset, Haraldsen, Riss. Discovery of a lead brain-penetrating gonadotropin-releasing hormone receptor antagonist with saturable binding in brain. ChemMedChem. 2020;15(17):1624-1628 | en_US |
dc.identifier.cristinID | FRIDAID 1823124 | |
dc.identifier.doi | 10.1002/cmdc.202000256 | |
dc.identifier.issn | 1860-7179 | |
dc.identifier.issn | 1860-7187 | |
dc.identifier.uri | https://hdl.handle.net/10037/20217 | |
dc.language.iso | eng | en_US |
dc.publisher | Wiley | en_US |
dc.relation.journal | ChemMedChem | |
dc.rights.accessRights | openAccess | en_US |
dc.rights.holder | Copyright 2020 The Author(s) | en_US |
dc.subject | VDP::Medical disciplines: 700::Health sciences: 800 | en_US |
dc.subject | VDP::Medisinske Fag: 700::Helsefag: 800 | en_US |
dc.title | Discovery of a lead brain-penetrating gonadotropin-releasing hormone receptor antagonist with saturable binding in brain | en_US |
dc.type.version | publishedVersion | en_US |
dc.type | Journal article | en_US |
dc.type | Tidsskriftartikkel | en_US |
dc.type | Peer reviewed | en_US |